Research highlights from the International Journal of Nanomedicine 2014

Sarah H Mian, Neel A Patel, Farina Shah, Sateesh B Arja, Farooq A ShiekhDepartment of Basic Medical Sciences, Avalon University School of Medicine, Curaçao, Netherlands AntillesCan nanocarriers conquer gene therapy?Evaluation of: Magalhães M, Farinha D, Pedroso de Lima MC, Fan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mian SH, Patel NA, Shah F, Arja SB, Shiekh FA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/fa33212d9c7747bb807dfaabf7293d6b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa33212d9c7747bb807dfaabf7293d6b
record_format dspace
spelling oai:doaj.org-article:fa33212d9c7747bb807dfaabf7293d6b2021-12-02T05:09:41ZResearch highlights from the International Journal of Nanomedicine 20141178-2013https://doaj.org/article/fa33212d9c7747bb807dfaabf7293d6b2015-03-01T00:00:00Zhttp://www.dovepress.com/research-highlights-from-the-international-journalnbspof-nanomedicine--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Sarah H Mian, Neel A Patel, Farina Shah, Sateesh B Arja, Farooq A ShiekhDepartment of Basic Medical Sciences, Avalon University School of Medicine, Curaçao, Netherlands AntillesCan nanocarriers conquer gene therapy?Evaluation of: Magalhães M, Farinha D, Pedroso de Lima MC, Faneca H. Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid. Int J Nanomedicine. 2014;9:4979–4989. Hepatocellular carcinoma (HCC) is a devastating disease that makes up 70%–85% of all cases of liver cancer, affecting millions of people worldwide.1 Unfortunately, HCC is aggressive and deadly; patients typically live for only 6 to 20 months after diagnosis, highlighting the dire need for new effective therapies. Although gene therapy has the potential to offer new biologically based medicines, the efficient, selective, and safe delivery of DNA- or RNA-based drugs to target cells including hepatocytes is still a major limiting factor to the broad applications of gene therapy in cancer diseases.2–4Mian SHPatel NAShah FArja SBShiekh FADove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2015, Iss default, Pp 2503-2505 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Mian SH
Patel NA
Shah F
Arja SB
Shiekh FA
Research highlights from the International Journal of Nanomedicine 2014
description Sarah H Mian, Neel A Patel, Farina Shah, Sateesh B Arja, Farooq A ShiekhDepartment of Basic Medical Sciences, Avalon University School of Medicine, Curaçao, Netherlands AntillesCan nanocarriers conquer gene therapy?Evaluation of: Magalhães M, Farinha D, Pedroso de Lima MC, Faneca H. Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid. Int J Nanomedicine. 2014;9:4979–4989. Hepatocellular carcinoma (HCC) is a devastating disease that makes up 70%–85% of all cases of liver cancer, affecting millions of people worldwide.1 Unfortunately, HCC is aggressive and deadly; patients typically live for only 6 to 20 months after diagnosis, highlighting the dire need for new effective therapies. Although gene therapy has the potential to offer new biologically based medicines, the efficient, selective, and safe delivery of DNA- or RNA-based drugs to target cells including hepatocytes is still a major limiting factor to the broad applications of gene therapy in cancer diseases.2–4
format article
author Mian SH
Patel NA
Shah F
Arja SB
Shiekh FA
author_facet Mian SH
Patel NA
Shah F
Arja SB
Shiekh FA
author_sort Mian SH
title Research highlights from the International Journal of Nanomedicine 2014
title_short Research highlights from the International Journal of Nanomedicine 2014
title_full Research highlights from the International Journal of Nanomedicine 2014
title_fullStr Research highlights from the International Journal of Nanomedicine 2014
title_full_unstemmed Research highlights from the International Journal of Nanomedicine 2014
title_sort research highlights from the international journal of nanomedicine 2014
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/fa33212d9c7747bb807dfaabf7293d6b
work_keys_str_mv AT miansh researchhighlightsfromtheinternationaljournalnbspofnanomedicine2014
AT patelna researchhighlightsfromtheinternationaljournalnbspofnanomedicine2014
AT shahf researchhighlightsfromtheinternationaljournalnbspofnanomedicine2014
AT arjasb researchhighlightsfromtheinternationaljournalnbspofnanomedicine2014
AT shiekhfa researchhighlightsfromtheinternationaljournalnbspofnanomedicine2014
_version_ 1718400570208813056